Sentinel Node Biopsy: From guidelines to practice | 5 hrs
321
students
0
Free
Sentinel node biopsy (SNB) has revolutionised the management of melanoma patients through accurate staging and helping to guide therapeutic decision-making. Learning the subtleties of...
Free
Melanoma awareness with Prof Richard Scolyer | 42 min
480
students
0
Free
In this interview for the Derm Club Podcast, Pathologist Prof Richard Scolyer AO provides an overview of melanoma and the public health challenge we...
Free
How to diagnose borderline cutaneous melanocytic lesions | 98 min
519
students
0
Free
In this recorded webinar from pathCast, Pathologists Prof Richard Scolyer AO, A/Prof Andrew Dettrick and Dr Nigel Maher discuss: Background to borderline melanocytic lesions...
Free
Neoadjuvant immunotherapy: Revolutionising melanoma treatment | 36 min
833
students
0
Free
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...
Free
The role of PRAME immunohistochemistry in the diagnostic approach to melanocytic lesions | 30 min
910
students
0
Free
PRAME is a tumour-associated antigen identified by autologous T-cell epitope in a patient with metastatic cutaneous melanoma. In this presentation Pathologist Dr Robert Rawson...
Free
Unravelling lentigo maligna | 48 min
971
students
1
Free
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshiladze leads...
Free
The critical role of standardised pathological assessment in neoadjuvant therapy for melanoma: A guide for Pathologists | 40 min
1079
students
0
Free
The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...
Free
Diagnosis and management of uveal melanoma | 44 min
1091
students
0
Free
Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic...
Free
Refining pathological response assessment in neoadjuvant therapy for melanoma | 40 min
1128
students
1
Free
In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated...
Free